Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. HGHAX: which is better?

Bottom line

PRHSX vs HGHAX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 65% by weight.

But PRHSX is far broader, holding 279 positions to 80 for HGHAX, so beyond the top names it adds exposure HGHAX doesn't have.

PRHSX is cheaper at 0.83% vs 1.33% — a difference of $50 a year per $10,000 invested.

HGHAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

PRHSX vs HGHAX side by side

PRHSXHGHAX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceHartford
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%1.33%
Annual cost per $10k$83$133
10-yr cost on $10k (prospectus)$1,025$2,063
Max front load—5.5%
12b-1 fee—0.25%
1-yr return+17.7%—
5-yr return (annualized)+4.2%—
10-yr return (annualized)+9.1%—
Best quarter+23.5%+20.9%
Worst quarter−15.8%−15.7%
Net assets (fund)$11.9B$772.2M
Number of holdings27980
Portfolio turnover62%49%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXHGHAXDifference
2025+17.7%+15.6%+2.1%
2024+1.8%0.0%+1.8%
2023+3.1%+3.8%−0.7%
2022−12.2%−11.7%−0.5%
2021+13.3%+10.0%+3.3%
2020+30.1%+22.6%+7.5%
2019+29.1%+33.3%−4.2%
2018+1.2%−3.0%+4.2%
2017+28.0%+21.6%+6.4%
2016−10.4%−8.6%−1.8%

Source: Fund prospectus bar charts

Holdings overlap

14 of PRHSX's top 25 holdings also appear in HGHAX's top 25.

Shared top holdings
HoldingPRHSXHGHAX
Eli Lilly & Co14.28%12.03%
Johnson & Johnson6.63%6.75%
Unitedhealth Group Inc5.99%4.74%
Abbvie Inc5.10%4.21%
Merck & Co. Inc.4.01%6.00%
Thermo Fisher Scientific Inc2.52%1.58%
Vertex Pharmaceuticals Inc2.28%2.64%
Abbott Laboratories1.89%1.82%
Intuitive Surgical Inc1.87%2.88%
Amgen Inc1.82%1.39%
Stryker Corp1.78%1.24%
Elevance Health Inc1.53%3.00%
Danaher Corp1.43%2.57%
Cvs Health Corp0.94%2.84%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

HGHAX top 10

  1. Eli Lilly & Co — 12.03%
  2. Johnson & Johnson — 6.75%
  3. Merck & Co Inc — 6.00%
  4. UnitedHealth Group Inc — 4.74%
  5. AbbVie Inc — 4.21%
  6. Elevance Health Inc — 3.00%
  7. Intuitive Surgical Inc — 2.88%
  8. CVS Health Corp — 2.84%
  9. Vertex Pharmaceuticals Inc — 2.64%
  10. Danaher Corp — 2.57%

FAQ

What is the difference between PRHSX and HGHAX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 65% by weight. But PRHSX is far broader, holding 279 positions to 80 for HGHAX, so beyond the top names it adds exposure HGHAX doesn't have.
Which is cheaper, PRHSX or HGHAX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and HGHAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.